{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:37:34Z","timestamp":1791859054638,"version":"4.3.4"},"reference-count":84,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T00:00:00Z","timestamp":1584403200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Behav. Neurosci."],"DOI":"10.3389\/fnbeh.2020.00032","type":"journal-article","created":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T01:44:54Z","timestamp":1584409494000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":27,"title":["Cannabidiol (CBD) Inhibited Rhodamine-123 Efflux in Cultured Vascular Endothelial Cells and Astrocytes Under Hypoxic Conditions"],"prefix":"10.3389","volume":"14","author":[{"given":"Jer\u00f3nimo","family":"Auzmendi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Palestro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agust\u00edn","family":"Blachman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana","family":"Gavernet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amalia","family":"Merelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Talevi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graciela Cristina","family":"Calabrese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto Javier","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Lazarowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,3,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.1535-7597.2004.04501.x","article-title":"Endocannabinoids and their implications for epilepsy.","volume":"4","author":"Alger","year":"2004","journal-title":"Epilepsy Curr."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1126\/science.1168750","article-title":"Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding.","volume":"323","author":"Aller","year":"2009","journal-title":"Science"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/ph11010021","article-title":"Pilocarpine-induced status epilepticus is associated with P-glycoprotein induction in cardiomyocytes.","volume":"11","author":"Auzmendi","year":"2018","journal-title":"Pharmaceuticals (Basel)"},{"key":"B4","first-page":"1","article-title":"Progressive heart P-glycoprotein (P-gp) overexpression after experimental repetitive seizures (ERS) associated with fatal status epilepticus (FSE). Is it related with SUDEP?","volume":"1","author":"Auzmendi","year":"2014","journal-title":"Smart Sci. Technol. Mol. Cell. Epilepsy"},{"key":"B5","doi-asserted-by":"publisher","first-page":"6732","DOI":"10.2174\/1381612811319380006","article-title":"P-glycoprotein contributes to cell membrane depolarization of hippocampus and neocortex in a model of repetitive seizures induced by pentylenetetrazole in rats.","volume":"19","author":"Auzmendi","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"B6","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1111\/j.1471-4159.2009.06535.x","article-title":"Intermittent hypoxia during sleep induces reactive gliosis and limited neuronal death in rats: implications for sleep apnea.","volume":"112","author":"Aviles-Reyes","year":"2010","journal-title":"J. Neurochem."},{"key":"B7","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1111\/jnc.14098","article-title":"Endocannabinoid system in neurodegenerative disorders.","volume":"142","author":"Basavarajappa","year":"2017","journal-title":"J. Neurochem."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.freeradbiomed.2011.01.007","article-title":"Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress.","volume":"51","author":"Booz","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.2081","article-title":"ABC transporters P-gp and Bcrp do not limit the brain uptake of the novel antipsychotic and anticonvulsant drug cannabidiol in mice.","volume":"4","author":"Brzozowska","year":"2016","journal-title":"PeerJ"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1016\/j.bmc.2015.01.059","article-title":"Cannabidiol (CBD) and its analogs: a review of their effects on inflammation.","volume":"23","author":"Burstein","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"B11","doi-asserted-by":"publisher","first-page":"481","DOI":"10.14670\/HH-26.481","article-title":"Decorin and biglycan expression: its relation with endothelial heterogeneity.","volume":"26","author":"Calabrese","year":"2011","journal-title":"Histol. Histopathol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1007\/s12640-009-9038-9","article-title":"Neuronal and glial alterations due to focal cortical hypoxia induced by direct cobalt chloride (CoCl2) brain injection.","volume":"15","author":"Caltana","year":"2009","journal-title":"Neurotox. Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"217","DOI":"10.5694\/mja18.00023","article-title":"Cannabidiol for treating drug-resistant epilepsy in children: the New South Wales experience.","volume":"209","author":"Chen","year":"2018","journal-title":"Med. J. Aust."},{"key":"B14","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1093\/intimm\/dxu097","article-title":"The differential characterization of GPR55 receptor in human peripheral blood reveals a distinctive expression in monocytes and NK cells and a proinflammatory role in these innate cells.","volume":"27","author":"Chiurchi\u00f9","year":"2015","journal-title":"Int. Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1111\/epi.12635","article-title":"The case for assessing cannabidiol in epilepsy.","volume":"55","author":"Cilio","year":"2014","journal-title":"Epilepsia"},{"key":"B16","first-page":"3387","article-title":"Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene.","volume":"62","author":"Comerford","year":"2002","journal-title":"Cancer Res."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2019.00005","article-title":"Ketogenic diet and epilepsy: what we know so far.","volume":"13","author":"D\u2019Andrea Meira","year":"2019","journal-title":"Front. Neurosci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"728","DOI":"10.2174\/1871527317666180828121820","article-title":"Effect of neuroinflammation on ABC transporters: possible contribution to refractory epilepsy.","volume":"17","author":"Deng","year":"2018","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"B19","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.ejphar.2006.11.030","article-title":"Endocannabinoids block status epilepticus in cultured hippocampal neurons.","volume":"558","author":"Deshpande","year":"","journal-title":"Eur. J. Pharmacol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.neulet.2006.09.046","article-title":"Cannabinoid CB1 receptor antagonists cause status epilepticus-like activity in the hippocampal neuronal culture model of acquired epilepsy.","volume":"411","author":"Deshpande","year":"","journal-title":"Neurosci. Lett."},{"key":"B21","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/epi.14628","article-title":"Long-term cannabidiol treatment in patients with Dravet syndrome: an open-label extension trial.","volume":"60","author":"Devinsky","year":"2019","journal-title":"Epilepsia"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.brs.2019.05.011","article-title":"Vagus nerve stimulation in refractory and super-refractory status epilepticus \u2013 a systematic review.","volume":"12","author":"Dibu\u00e9-Adjei","year":"2019","journal-title":"Brain Stimul."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1007\/s10815-015-0553-8","article-title":"Marijuana, phytocannabinoids, the endocannabinoid system, and male fertility.","volume":"32","author":"du Plessis","year":"2015","journal-title":"J. Assist. Reprod. Genet."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.153","article-title":"Cannabidiol changes P-gp and BCRP expression in trophoblast cell lines.","volume":"1","author":"Feinshtein","year":"2013","journal-title":"PeerJ"},{"key":"B25","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3978\/j.issn.2224-4336.2015.10.03","article-title":"Cannabinoids for pediatric epilepsy? Up in smoke or real science?","volume":"4","author":"Filloux","year":"2015","journal-title":"Transl. Pediatr."},{"key":"B26","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1056\/nejmc1512758","article-title":"Cannabinoids in the treatment of epilepsy.","volume":"374","author":"Friedman","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1523\/jneurosci.09-01-00183.1989","article-title":"Lipopolysaccharide-free conditions in primary astrocyte cultures allow growth and isolation of microglial cells.","volume":"9","author":"Gebicke-Haerter","year":"1989","journal-title":"J. Neurosci."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1523\/jneurosci.06-08-02163.1986","article-title":"Characterization of ameboid microglia isolated from developing mammalian brain.","volume":"6","author":"Giulian","year":"1986","journal-title":"J. Neurosci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"205","DOI":"10.2176\/nmc.ra.2015-0344","article-title":"The new antiepileptic drugs: their neuropharmacology and clinical indications.","volume":"56","author":"Hanaya","year":"2016","journal-title":"Neurol. Med. Chir. (Tokyo)"},{"key":"B30","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1021\/acs.molpharmaceut.6b00770","article-title":"P-gp protein expression and transport activity in rodent seizure models and human epilepsy.","volume":"14","author":"Hartz","year":"2017","journal-title":"Mol. Pharm."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1111\/bph.12615","article-title":"Cannabidiol enhances microglial phagocytosis via transient receptor potential (TRP) channel activation.","volume":"171","author":"Hassan","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"680","DOI":"10.4103\/ijccm.IJCCM_250_18","article-title":"Verapamil as an adjuvant treatment for drug-resistant epilepsy.","volume":"22","author":"Hisham","year":"2018","journal-title":"Indian J. Crit. Care Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"295","DOI":"10.2174\/156800906777441753","article-title":"Regulation of multidrug resistance by pro-inflammatory cytokines.","volume":"6","author":"Ho","year":"2006","journal-title":"Curr. Cancer Drug Targets"},{"key":"B34","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.neulet.2006.11.075","article-title":"Nimodipine restores the altered hippocampal phenytoin pharmacokinetics in a refractory epileptic model.","volume":"413","author":"H\u00f6cht","year":"2007","journal-title":"Neurosci. Lett."},{"key":"B35","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1038\/sj.bjp.0707467","article-title":"The multidrug transporter ABCG2 (BCRP) is inhibited by plant-derived cannabinoids.","volume":"152","author":"Holland","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/j.bcp.2005.12.033","article-title":"The effects of cannabinoids on P-glycoprotein transport and expression in multidrug resistant cells.","volume":"71","author":"Holland","year":"2006","journal-title":"Biochem. Pharmacol."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-019-0933-z","article-title":"Intractable generalized epilepsy: therapeutic approaches.","volume":"19","author":"Hwang","year":"2019","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1021\/cn5000524","article-title":"Nonpsychotropic plant cannabinoids, cannabidivarin (CBDV) and cannabidiol (CBD), activate and desensitize transient receptor potential vanilloid 1 (TRPV1) channels in vitro: potential for the treatment of neuronal hyperexcitability.","volume":"5","author":"Iannotti","year":"2014","journal-title":"ACS Chem. Neurosci."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1002\/hep.510260613","article-title":"Modulation of liver canalicular transport processes by the tyrosine-kinase inhibitor genistein: implications of genistein metabolism in the rat.","volume":"26","author":"J\u00e4ger","year":"1997","journal-title":"Hepatology"},{"key":"B40","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1007\/s11030-014-9550-6","article-title":"Pregnane X receptor and P-glycoprotein: a connexion for Alzheimer\u2019s disease management.","volume":"18","author":"Jain","year":"2014","journal-title":"Mol. Divers."},{"key":"B41","doi-asserted-by":"publisher","first-page":"203","DOI":"10.2147\/JIR.S163248","article-title":"A review of vagus nerve stimulation as a therapeutic intervention.","volume":"11","author":"Johnson","year":"2018","journal-title":"J. Inflamm. Res."},{"key":"B42","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1056\/nejm200002033420503","article-title":"Early Identification of refractory epilepsy.","volume":"342","author":"Kwan","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/s1474-4422(09)70304-7","article-title":"Definition of refractory epilepsy: defining the indefinable?","volume":"9","author":"Kwan","year":"2010","journal-title":"Lancet Neurol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jns.2007.03.004","article-title":"Neuronal mdr-1 gene expression after experimental focal hypoxia: a new obstacle for neuroprotection?","volume":"258","author":"Lazarowski","year":"","journal-title":"J. Neurol. Sci."},{"key":"B45","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/j.1528-1167.2007.01302.x","article-title":"ABC transporters during epilepsy and mechanisms underlying multidrug resistance in refractory epilepsy.","volume":"48","author":"Lazarowski","year":"","journal-title":"Epilepsia"},{"key":"B46","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/s0887-8994(03)00407-7","article-title":"Multidrug resistance proteins in tuberous sclerosis and refractory epilepsy.","volume":"30","author":"Lazarowski","year":"","journal-title":"Pediatr. Neurol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1023\/b:cemn.0000012726.43842.d2","article-title":"Neuronal and glial expression of the multidrug resistance gene product in an experimental epilepsy model.","volume":"24","author":"Lazarowski","year":"","journal-title":"Cell. Mol. Neurobiol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/s0887-8994(99)00074-0","article-title":"Tuberous sclerosis associated with MDR1 gene expression and drug-resistant epilepsy.","volume":"21","author":"Lazarowski","year":"1999","journal-title":"Pediatr. Neurol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.phrs.2019.04.031","article-title":"ABC transporters in drug-resistant epilepsy: mechanisms of upregulation and therapeutic approaches.","volume":"144","author":"Leandro","year":"2019","journal-title":"Pharmacol. Res."},{"key":"B50","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/epi4.12098","article-title":"Ketogenic diet for treatment of intractable epilepsy in adults: a meta-analysis of observational studies.","volume":"3","author":"Liu","year":"2018","journal-title":"Epilepsia Open"},{"key":"B51","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/nrd4126","article-title":"New avenues for anti-epileptic drug discovery and development.","volume":"12","author":"L\u00f6scher","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"B52","doi-asserted-by":"publisher","first-page":"2808","DOI":"10.2174\/138161211797440212","article-title":"Do ATP-binding cassette transporters cause pharmacoresistance in epilepsy? Problems and approaches in determining which antiepileptic drugs are affected.","volume":"17","author":"L\u00f6scher","year":"2011","journal-title":"Curr. Pharm. Des."},{"key":"B53","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1124\/jpet.301.1.7","article-title":"Role of multidrug transporters in pharmacoresistance to antiepileptic drugs.","volume":"301","author":"L\u00f6scher","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B54","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1111\/epi.12610","article-title":"The case for medical marijuana in epilepsy.","volume":"55","author":"Maa","year":"2014","journal-title":"Epilepsia"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1111\/j.1476-5381.2011.01277.x","article-title":"Cannabinoid receptor signalling in neurodegenerative diseases: a potential role for membrane fluidity disturbance.","volume":"163","author":"Maccarrone","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.yebeh.2013.08.029","article-title":"Systems biology, complexity, and the impact on antiepileptic drug discovery.","volume":"38","author":"Margineanu","year":"2014","journal-title":"Epilepsy Behav."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biosystems.2015.11.010","article-title":"Neuropharmacology beyond reductionism \u2013 a likely prospect.","volume":"141","author":"Margineanu","year":"2016","journal-title":"BioSystems"},{"key":"B58","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1126\/science.1088208","article-title":"CB1 cannabinoid receptors and on-demand defense against excitotoxicity.","volume":"302","author":"Marsicano","year":"2003","journal-title":"Science"},{"key":"B59","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/nrd1495","article-title":"The endocannabinoid system and its therapeutic exploitation.","volume":"3","author":"Marzo","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"B60","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/s12640-010-9233-8","article-title":"Recovery of motor spontaneous activity after intranasal delivery of human recombinant erythropoietin in a focal brain hypoxia model induced by CoCl2 in rats.","volume":"20","author":"Merelli","year":"","journal-title":"Neurotox. Res."},{"key":"B61","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1515\/DMDI.2011.007","article-title":"Experimental evidence of the potential use of erythropoietin by intranasal administration as a neuroprotective agent in cerebral hypoxia.","volume":"26","author":"Merelli","year":"","journal-title":"Drug Metabol. Drug Interact."},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2019.00750","article-title":"Convulsive stress mimics brain hypoxia and promotes the P-glycoprotein (P-gp) and erythropoietin receptor overexpression. Recombinant human erythropoietin effect on P-gp activity.","volume":"13","author":"Merelli","year":"2019","journal-title":"Front. Neurosci."},{"key":"B63","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1097\/00008877-200509000-00017","article-title":"Behavioural effects of quinpirole following withdrawal of chronic treatment with the CB1 agonist, HU-210, in rats.","volume":"16","author":"Moreno","year":"2005","journal-title":"Behav. Pharmacol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/414916a","article-title":"Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage.","volume":"414","author":"Ohta","year":"2001","journal-title":"Nature"},{"key":"B65","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1124\/pr.58.3.2","article-title":"The endocannabinoid system as an emerging target of pharmacotherapy.","volume":"58","author":"Pacher","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1021\/acs.jcim.7b00721","article-title":"Searching for new leads to treat epilepsy: target-based virtual screening for the discovery of anticonvulsant agents.","volume":"58","author":"Palestro","year":"2018","journal-title":"J. Chem. Inf. Model."},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/358425","article-title":"Docking applied to the prediction of the affinity of compounds to p-glycoprotein.","volume":"2014","author":"Palestro","year":"2014","journal-title":"Biomed Res. Int."},{"key":"B68","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jps.21831","article-title":"Effects of P-glycoprotein and Mrp2 inhibitors on the hepatobiliary disposition of rhodamine 123 and its glucuronidated metabolite in isolated perfused rat livers.","volume":"99","author":"Parasrampuria","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"B69","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1054\/plef.2001.0341","article-title":"Cannabinoid receptors and their ligands.","volume":"66","author":"Pertwee","year":"2002","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1124\/mol.108.046680","article-title":"P-glycoprotein\u2013a clinical target in drug-refractory epilepsy?","volume":"73","author":"Robey","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/epi4.12376","article-title":"Is cannabidiol a drug acting on unconventional targets to control drug\u2212resistant epilepsy?","volume":"5","author":"Rocha","year":"2020","journal-title":"Epilepsia Open"},{"key":"B72","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/s13311-015-0375-5","article-title":"Cannabinoids and epilepsy.","volume":"12","author":"Rosenberg","year":"2015","journal-title":"Neurotherapeutics"},{"key":"B73","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/j.1476-5381.2010.00735.x","article-title":"The endocannabinoid system as a target for the treatment of neurodegenerative disease.","volume":"160","author":"Scotter","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1152\/physiol.00045.2008","article-title":"Regulation of oxygen homeostasis by hypoxia-inducible factor 1.","volume":"24","author":"Semenza","year":"2009","journal-title":"Physiology"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1080\/17460441.2016.1216965","article-title":"Computational approaches for innovative antiepileptic drug discovery.","volume":"11","author":"Talevi","year":"2016","journal-title":"Expert Opin. Drug Discov."},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2017.00301","article-title":"Drug-resistant epilepsy: multiple hypotheses, few answers.","volume":"8","author":"Tang","year":"2017","journal-title":"Front. Neurol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/bs.irn.2015.09.003","article-title":"Endocannabinoid regulation of neuroendocrine systems.","volume":"125","author":"Tasker","year":"2015","journal-title":"Int. Rev. Neurobiol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1528-1157.1995.tb01657.x","article-title":"MDR1 gene expression in brain of patients with medically intractable epilepsy.","volume":"36","author":"Tishler","year":"1995","journal-title":"Epilepsia"},{"key":"B79","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading.","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1111\/epi.14505","article-title":"The expression of inflammatory markers and their potential influence on efflux transporters in drug-resistant mesial temporal lobe epilepsy tissue.","volume":"59","author":"Weidner","year":"2018","journal-title":"Epilepsia"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2018.00602","article-title":"MicroRNA-298 reverses multidrug resistance to antiepileptic drugs by suppressing MDR1\/P-gp expression in vitro.","volume":"12","author":"Xie","year":"2018","journal-title":"Front. Neurosci."},{"key":"B82","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.26355\/eurrev_201804_14829","article-title":"The effect of miR-146a gene silencing on drug-resistance and expression of protein of P-gp and MRP1 in epilepsy.","volume":"22","author":"Zhang","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"B83","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s12282-017-0821-9","article-title":"Schisandrin A reverses doxorubicin-resistant human breast cancer cell line by the inhibition of P65 and Stat3 phosphorylation.","volume":"25","author":"Zhang","year":"2018","journal-title":"Breast Cancer"},{"key":"B84","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1124\/jpet.105.098541","article-title":"Characterization of P-glycoprotein inhibition by major cannabinoids from marijuana.","volume":"317","author":"Zhu","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Frontiers in Behavioral Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnbeh.2020.00032\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T01:44:59Z","timestamp":1584409499000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnbeh.2020.00032\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,17]]},"references-count":84,"alternative-id":["10.3389\/fnbeh.2020.00032"],"URL":"https:\/\/doi.org\/10.3389\/fnbeh.2020.00032","relation":{},"ISSN":["1662-5153"],"issn-type":[{"value":"1662-5153","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,17]]},"article-number":"32"}}